“Dextran Conjugation of Non–Steroidal Anti-Inflammatory Drug (Etodolac): A Colon Targeting Approach: Development of a Glucosamine-Conjugated Etodolac Prodrug for Improved Targeting and Reduced Side Effects”. Journal of Advances and Scholarly Researches in Allied Education 16, no. 6 (May 1, 2019): 3589–3595. Accessed April 4, 2026. https://ignited.in/index.php/jasrae/article/view/11970.